Glomerular hyperfiltration in hypertensive African Americans

Hypertension

Volumn 35, Issue 3, 2000, Pages 822-826

  Kotchen, Theodore A ^a   Piering, Andrew W ^a   Cowley, Allen W ^a   Grim, Clarence E ^a   Gaudet, Daniel ^b   Hamet, Pavel ^b   Kaldunski, Mary L ^a   Kotchen, Jane M ^a   Roman, Richard J ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Blood pressure monitoring, ambulatory; Glomerular filtration rate; Norepinephrine; Plasma renin activity; Renal blood flow

Indexed keywords

NORADRENALIN;

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL ARTICLE; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; GLOMERULUS FILTRATION; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY BLOOD FLOW; KIDNEY FAILURE; NEGRO; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RACE DIFFERENCE;

EID: 0034117888     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.35.3.822     Document Type: Article

References (57)

1. Klag MJ, Whelton PK, Randall BI, Neaton JD, Brancati FL, Ford CE, Shulman NB, Stamler J. Blood pressure and end-stage renal disease in men. N Engl J Med. 1996;334:13-18.
2. Shulman NB, Ford CE, Hall DW, Blaufox MD, Simon D, Langford HG, Schneider KA, on behalf of the Hypertension Detection and Follow-Up Program Cooperative Group. Prognostic value of serum creatinine and effect of treatment of hypertension on renal function: results from the Hypertension Detection and Follow-up Program. Hypertension. 1989;13(suppl I):I-80-1-93.
3. Walker WG, Neaton JD, Cutler JA, Neuwirth R, Cohen JD, for the MRFIT Research Group. Renal function change in hypertensive members of the Multiple Risk Factor Intervention Trial: racial and treatment effects. JAMA. 1992;268:3085-3091.
4. Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancat FL, Stamler J. End-stage renal disease in African-American and white men. JAMA. 1997; 277:1293-1298.
5. US Renal Data System. USRDS 1994 Annual Data Report. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 1994.
6. Ferguson R, Grim CE, Opgenorth TJ. The epidemiology of end-stage renal disease: the six year south central Los Angeles experience. Am J Public Health. 1987;77:864-865.
7. Whelton PK, Klag, MJ. Hypertension as a risk for renal disease: review of clinical and epidemiological evidence. Hypertension. 1989;13(suppl I)I-19-1-27.
8. Toto RD, Mitchell HC, Smith RD, Lee HC, McIntire D, Pettinger WA. "Strict" blood pressure control and progression of renal disease in hypertensive nephrosclerosis. Kidney Int. 1995;48:851-859.
9. Rostand S, Brown G, Kirk K, Rutsky E, Dustan H. Renal insufficiency in treated essential hypertension. N Engl J Med. 1981;320:684-688.
10. Rostand SG. Hypertension and renal disease in blacks: role of genetic and/or environmental factors? Adv Nephrol 1992;21:99-116.
11. Freedman BI, Spray BJ, Tuttle AB, Buckalew VM. The familial risk of end-stage renal disease in African Americans. Am J Kidney Dis. 1993;21: 387-393.
12. Ferguson R, Grim CE, Opgenorth TJ. A familial risk of chronic renal failure among blacks on dialysis. J Clin Epidemiol. 1988;41:1189-1196.
13. Brown DM, Provoost AP, Daly MJ, Lander ES, Jacob HJ. Renal disease susceptibility and hypertension are under independent genetic control in the fawn-hooded rat. Nat Genet. 1996;12:44-51.
14. Churchill PC, Churchill MC, Bidani AK, Griffin KA, Picken M, Pravenec M, Kren V, St Lezin E, Wang JM, Wang N, Kurtz TW. Genetic susceptibility to hypertension-induced renal damage in the rat: evidence based on kidney-specific genome transfer. J Clin Invest. 1997;100:1373-1382.
15. Helmchen U, Wenzel UO. Benign and malignant nephrosclerosis and renovascular disease. In: Tisher CC, Brenner BM, eds. Renal Pathology: With Clinical and Functional Correlations. 2nd ed. Philadelphia, Pa: JB Lippincott Co; 1994:1201-1236.
16. Mountokalakis TD. The renal consequences of arterial hypertension. Kidney Int. 1997;51:1639-1653.
17. Brenner B. Hemodynamically mediated glomerular injury and the progressive nature of kidney disease. Kidney Int. 1983;23:647-655.
18. Schmieder RE, Messerli FH, Garavglia G, Nunez B. Glomerular hyperfiltration indicates early target organ damage in essential hypertension. JAMA. 1990;264:2775-2780.
19. Johnston CI, Risvasi J, Naitoh M, Tikkanen I. Mechanism of progression of renal disease: current hemodynamic concepts. J Hypertens. 1998;16(suppl 4):S3-S7.
20. Rennke HG, Anderson S, Brenner BM. The progression of renal disease: structural and functional correlations. In: Tisher CC, Brenner BM, eds. Renal Pathology: With Clinical and Functional Correlations. 2nd ed. Philadelphia, Pa: JB Lippincott Co: 1994:116-142.
21. Hostetter TH, Rennke HG, Brenner BM. The case for intrarenal hypertension in the initiation and progression of diabetes and other glomerulopathies. Am J Med. 1982;72:375-380.
22. Morgensen CE, Christensen CK. Predicting diabetic nephropathy in insulin-dependent diabetes. N Engl J Med. 1984;311:89-93.
23. Rudberg S, Persson B, Dahlquist G. Increased GFR as a predictor of diabetic kidney disease: an 8 year prospective study. Kidney Int. 1992;41:822-828.
24. Schmieder RE, Veelken R, Gatzka CD, Ruddel H, Schachinger H. Predictors for hypertensive nephropathy: results of 6 year follow-up study in essential hypertension. J Hypertens. 1995;13:357-365.
25. Schnurr E, Lahme W, Kuppers H. Measurement of renal clearance of inulin and PAH in the steady state without urine collection. Clin Nephrol. 1980; 13:26-29.
26. Ronnhedh C, Jaquenod M, Mather LE. Urineless estimation of glomerular filtration rate and renal plasma flow in the rat. J Pharmacol Toxicol Methods. 1996;36:123-129.
27. Hellerstein S, Berenbom M, Alon U, Warady BA. The renal clearance and infusion clearance of inulin are similar but not identical. Kidney Int. 1993; 44:1058-1061.
28. Smith, HW, Finkelstern N, Aliminosa L, Crawford B, Graber M. The renal clearance of substituted hippuric acid derivatives and other aromatic acids in dogs and man. J Clin Invest. 1945;24:388-404.
29. Conger JD, Rhoads HN, Christie SM, Burke TJ. A modification of the fluorescence method for micro-inulin determinations. Kidney Int 1975;8: 334-337.
30. Sealey JE, Laragh JH. How to do a plasma renin assay. Cardiovasc Med. 1977;2:1079-1092.
31. Perry HM Jr, Miller JP, Fornoff JR, Baty JD, Sambhi, MP Rutan G, Moskowitz DW, Carmody SE. Early predictors of 15 year end-stage renal disease in hypertensive patients. Hypertension. 1995;25:587-594.
32. Harshfield GA, Hwang C, Grim C. The circadian variation of blood pressure in blacks: influence of age, gender, and activity. J Hum Hypertens. 1990:4: 43-47.
33. Greller DD, Fumo MT, Nelson KS, Murphy MB. Ethnic differences in circadian hemodynamic profile. Am J Hypertens. 1994;7:7-14.
34. Maget J, Chapman N, Li CK-C, Shahi M, Poulter NR, Sever PS, Foote RA, Thom SA. Ethnic differences in the hypertensive heart and 24-hour blood pressure profile. Hypertension. 1998;31:1190-1194.
35. Profant J, Dimsdale JE. Race and diurnal blood pressure patterns: a review and meta-analysis. Hypertension. 1999;33:1099-1104.
36. Fumo MT, Teegers, Lang RM, Bednarz J, Sareli P, Murphy MB. Diurnal blood pressure variations and cardiac mass in American blacks and whites and South African blacks. Am J Hypertens. 1992;5:111-116.
37. Harshfield GA, Alpert BS, Willey ES, Somes GW, Murphy MK, Dupaul LM. Race and gender influence ambulatory blood pressure patterns of adolescents. Hypertension. 1989;14:598-603.
38. Lang RM, Borrow KM, Weinert L, Bednarz J, Neumann A, Nelson K, David D, Murphy CB. Circadian blood pressure patterns in hypertensive patients: importance of nocturnal blood pressure. Circulation. 1988;78(suppl II): II-517. Abstract.
39. O'Brien E, Sheridan J, O'Malaley K. Dippers and non-dippers. Lancet. 1988;2:397. Letter.
40. Verdecchia P, Schillaci G, Guerrieri M, Gatteschi C, Benemio G, Boldrini F, Porcellati C. Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation. 1990;81:528-536.
41. Palatini P, Penso M, Racioppa A, Zugno E, Guzzardi G, Anaclerio M, Pessina AC. Clinical relevance of nighttime blood pressure and of daytime blood pressure variability. Arch Intent Med. 1992;152:1855-186.
42. Verdecchia P, Porcellati C, Schillaci G, Borgioni C, Ciucci A, Battistelli M, Guerrieri M, Gatteschi C, Zampi I, Santucci A, Santucci C, Reboldi G. Ambulatory blood pressure: an independent predictor of prognosis in essential hypertension. Hypertension. 1994;24:793-801.
43. Zweiker R, Eber B, Schumacher M, Toplak H, Klein W. 'Non-dipping' related to cardiovascular events is essential hypertensive patients. Acta Med Austriaca. 1994;21:86-89.
44. Dimsdale JE, Graham RM, Ziegler MG, Zusman RM, Berg CC. Age, race, diagnosis and sodium effects on the pressor response to infused norepinephrine. Hypertension. 1987;10:564-569.
45. Ziegler MG, Mills P, Dimsdale JE. Hypertensives' pressor response to norepinephrine: analysis by infusion rate and plasma levels. Am J Hypertens. 1991;4:586-591.
46. Light KC, Obrist PA, Sherwood A, James SA, Strogatz DS. Effects of race and marginally elevated blood pressure on responses to stress. Hypertension. 1987;10:555-563.
47. Levy SB, Talner LB, Coel MN, Holle R, Stone RA. Renal vasculature in essential hypertension: racial differences. Ann Intern Med. 1978;88:12-16.
48. Frohlich ED, Messerli FH, Dunn FG, Oigman W, Ventura HO, Sundgaard-Riise K. Greater renal vascular involvement in the black patient with essential hypertension: a comparison of systemic and renal hemodynamics in black and white patients. Miner Electrolyte Metab. 1984;10: 173-177.
49. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D, for the Modification of Diet in Renal Disease Study Group. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med. 1994;130:461-470.
50. Parmer RJ, Stone RA, Cervenka JH. Renal hemodynamics in essential hypertension: racial differences in response to changes in dietary sodium. Hypertension. 1994;24:752-757.
51. Campese VM, Parise M, Karubian F, Bigazzi R, Abnormal renal hemodynamics in black salt-sensitive patients with hypertension. Hypertension. 1991; 18:805-812.
52. Schmidlin O, Forman A, Tanaka M, Sebastian A, Morris RC Jr. NaCl-induced renal vasoconstriction in salt-sensitive African Americans: antipressor and hemodynamic effects of potassium bicarbonate. Hypertension. 1999;33:633-639.
53. Ribstein J, du Cailar G, Mimran A. Combined renal effects of overweight and hypertension. Hypertension. 1995;26:610-615.
54. Roman RJ. Abnormal renal hemodynamics and pressure-natriuresis relationship in Dahl salt-sensitive rats. Am J Physiol. 1986;251:F57-F65.
55. Hall JE, Guyton AC, Cowley AW Jr. Dissociation of renal blood flow and filtration rate autoregulation by renin depletion. Am J Physiol. 1977:232: F215-F221.
56. He J, Klag MJ, Appel LJ, Charleston J, Whelton PK. The renin-angiotensin system and blood pressure: differences between blacks and whites. Am J Hypertens. 1999;12:555-562.
57. Van Dokkum RPE, Sun C-W, Provoost AP, Jacob HJ, Roman RJ. Altered renal hemodynamics and impaired myogenic responses in the fawn-hooded rat. Am J Physiol. 1999;276:R855-R863.